Akt/mTOR activation downstream of integrin-ECM interaction in HCC could increase CD133 synthesis via mTORC1 activation and PROM1 gene expression via Akt-mediated SOX2 protein stabilization [158, 165]. The gene discussed is PROM1; the disease is hepatocellular carcinoma.